About this trial
The goal of this study type: clinical trial\] is to learn the effect of Botulinum Toxin \_A injection in treatment of RT1andRT2 Gingival recession in lower anterior teeth .
Primary outcome is keratinzed tissue width. Researchers will compare Coronally Advanced flap with De-epithelized free gingival graft and Botulinum toxin-A injection in Mentalis muscle with coronally advanced flap with De-epithelized free gingival graft alone .
The outcome will be measured at baseline, after 3 months and after 6 mobths \_medical history
* 3 mm horizontal incisions, then two vertical incisions * deepitheliztion of anatomical papillae * superficial and deep incisions * harvesting DFGG * Suturing * BOTOX injection
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Single or multiple RT1, RT2 GR patient
patients ≥18 years
systemically healthy, full mouth plaque score, full mouth bleeding score ≤ 15% after phase I therapy
clinical indication and/or patient request for recession coverage
Disqualifiers
Pregnant or lactating women
Smokers' patients
Teeth with cervical restorations/abrasion.
Patients had a systemic condition affect blood components and healing
Trial design
Parallel
Treatments tested in this trial
Botulinum toxin-A injection
Procedure/SurgeryBotulinum toxin-A Injection Mentalis muscle in lower anterior teeth
Coronally advanced flap
Procedure/SurgeryCoronally Advanced Flap andDe-epithelized Free Gingival Graft
Treatment groups
Trial outcomes
Primary outcomes
Keratinized tissue width
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: